It is noteworthy to mention that recent studies have highlighted the fact that basal-type breast cancers disrupt the blood-brain barrier (BBB) during their metastasis to the brain [50], and that glucose transporter 1 (GLUT1) is specifically localized to the BBB [51]. Here, SLC2A1 is linked to breast cancer.